H.B. Fuller (NYSE:FUL) Now Covered by Analysts at StockNews.com

Equities research analysts at StockNews.com started coverage on shares of H.B. Fuller (NYSE:FULGet Rating) in a research note issued to investors on Thursday. The brokerage set a “hold” rating on the specialty chemicals company’s stock.

Other equities research analysts have also issued research reports about the company. Citigroup upgraded H.B. Fuller from a “neutral” rating to a “buy” rating and increased their target price for the company from $72.00 to $85.00 in a research note on Friday, February 3rd. Robert W. Baird lowered their price objective on H.B. Fuller from $85.00 to $80.00 and set an “outperform” rating for the company in a research note on Friday, January 20th. Finally, Deutsche Bank Aktiengesellschaft raised their price objective on H.B. Fuller from $72.00 to $78.00 in a research note on Friday, January 20th. One analyst has rated the stock with a sell rating, one has assigned a hold rating and three have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and a consensus target price of $73.75.

H.B. Fuller Price Performance

FUL stock opened at $65.08 on Thursday. The company has a debt-to-equity ratio of 1.08, a quick ratio of 1.14 and a current ratio of 1.84. H.B. Fuller has a 1 year low of $57.36 and a 1 year high of $81.41. The firm has a market cap of $3.50 billion, a P/E ratio of 19.96 and a beta of 1.54. The stock has a 50-day simple moving average of $70.70 and a 200-day simple moving average of $70.12.

Insider Transactions at H.B. Fuller

In other news, VP Timothy J. Keenan sold 2,836 shares of H.B. Fuller stock in a transaction that occurred on Thursday, February 9th. The stock was sold at an average price of $71.80, for a total value of $203,624.80. Following the completion of the transaction, the vice president now owns 19,803 shares in the company, valued at approximately $1,421,855.40. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Insiders own 4.50% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds have recently made changes to their positions in FUL. MetLife Investment Management LLC grew its position in shares of H.B. Fuller by 55.7% in the 1st quarter. MetLife Investment Management LLC now owns 27,833 shares of the specialty chemicals company’s stock worth $1,839,000 after acquiring an additional 9,960 shares in the last quarter. Luminus Management LLC bought a new stake in shares of H.B. Fuller in the 1st quarter worth approximately $3,396,000. Mutual of America Capital Management LLC lifted its holdings in shares of H.B. Fuller by 17.0% in the 2nd quarter. Mutual of America Capital Management LLC now owns 8,910 shares of the specialty chemicals company’s stock worth $536,000 after purchasing an additional 1,297 shares during the last quarter. Dorsey & Whitney Trust CO LLC lifted its holdings in shares of H.B. Fuller by 1.8% in the 2nd quarter. Dorsey & Whitney Trust CO LLC now owns 60,092 shares of the specialty chemicals company’s stock worth $3,618,000 after purchasing an additional 1,090 shares during the last quarter. Finally, UBS Asset Management Americas Inc. lifted its holdings in shares of H.B. Fuller by 4.9% in the 2nd quarter. UBS Asset Management Americas Inc. now owns 66,538 shares of the specialty chemicals company’s stock worth $4,006,000 after purchasing an additional 3,081 shares during the last quarter. Institutional investors and hedge funds own 96.53% of the company’s stock.

About H.B. Fuller

(Get Rating)

H.B. Fuller Co engages in the manufacture and marketing of adhesives, sealants, and other chemical products. It operates through the following business segments: Hygiene, Health, and Consumable Adhesives, Engineering Adhesives, and Construction Adhesives. The Hygiene, Health, and Consumable Adhesives segment supplies adhesive products in the assembly, packaging, converting, nonwoven, hygiene, health and beauty, flexible packaging, graphic arts, and envelope markets.

Featured Stories

Receive News & Ratings for H.B. Fuller Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for H.B. Fuller and related companies with MarketBeat.com's FREE daily email newsletter.